Literature DB >> 33799385

Mechanistic Insights into Alzheimer's Disease Unveiled through the Investigation of Disturbances in Central Metabolites and Metabolic Pathways.

Raúl González-Domínguez1,2, Álvaro González-Domínguez3, Ana Sayago1,2, Juan Diego González-Sanz4, Alfonso María Lechuga-Sancho3,5,6, Ángeles Fernández-Recamales1,2.   

Abstract

Hydrophilic metabolites are closely involved in multiple primary metabolic pathways and, consequently, play an essential role in the onset and progression of multifactorial human disorders, such as Alzheimer's disease. This review article provides a comprehensive revision of the literature published on the use of mass spectrometry-based metabolomics platforms for approaching the central metabolome in Alzheimer's disease research, including direct mass spectrometry, gas chromatography-mass spectrometry, hydrophilic interaction liquid chromatography-mass spectrometry, and capillary electrophoresis-mass spectrometry. Overall, mounting evidence points to profound disturbances that affect a multitude of central metabolic pathways, such as the energy-related metabolism, the urea cycle, the homeostasis of amino acids, fatty acids and nucleotides, neurotransmission, and others.

Entities:  

Keywords:  Alzheimer’s disease; central metabolic pathways; central metabolites; mass spectrometry

Year:  2021        PMID: 33799385      PMCID: PMC7998757          DOI: 10.3390/biomedicines9030298

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  68 in total

Review 1.  Metabolomics in Alzheimer's disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology.

Authors:  Raúl González-Domínguez; Ana Sayago; Ángeles Fernández-Recamales
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-02-06       Impact factor: 3.205

Review 2.  HILIC-MS for metabolomics: An attractive and complementary approach to RPLC-MS.

Authors:  Dao-Quan Tang; Ll Zou; Xiao-Xing Yin; Choon Nam Ong
Journal:  Mass Spectrom Rev       Date:  2014-10-03       Impact factor: 10.946

3.  Deregulation of purine metabolism in Alzheimer's disease.

Authors:  Belén Ansoleaga; Mariona Jové; Agatha Schlüter; Paula Garcia-Esparcia; Jesús Moreno; Aurora Pujol; Reinald Pamplona; Manuel Portero-Otín; Isidre Ferrer
Journal:  Neurobiol Aging       Date:  2014-08-08       Impact factor: 4.673

Review 4.  The molecular bases of Alzheimer's disease and other neurodegenerative disorders.

Authors:  R B Maccioni; J P Muñoz; L Barbeito
Journal:  Arch Med Res       Date:  2001 Sep-Oct       Impact factor: 2.235

5.  Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.

Authors:  Raúl González-Domínguez; Tamara García-Barrera; José Luis Gómez-Ariza
Journal:  J Pharm Biomed Anal       Date:  2014-12-13       Impact factor: 3.935

6.  Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model.

Authors:  Ze-Ping Hu; Edward R Browne; Tao Liu; Thomas E Angel; Paul C Ho; Eric Chun Yong Chan
Journal:  J Proteome Res       Date:  2012-10-29       Impact factor: 4.466

7.  Metabolite profiling of Alzheimer's disease cerebrospinal fluid.

Authors:  Christian Czech; Peter Berndt; Kristina Busch; Oliver Schmitz; Jan Wiemer; Veronique Most; Harald Hampel; Jürgen Kastler; Hans Senn
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

8.  Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease.

Authors:  Eugenia Trushina; Emirhan Nemutlu; Song Zhang; Trace Christensen; Jon Camp; Janny Mesa; Ammar Siddiqui; Yasushi Tamura; Hiromi Sesaki; Thomas M Wengenack; Petras P Dzeja; Joseph F Poduslo
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

9.  Metabolome in progression to Alzheimer's disease.

Authors:  M Orešič; T Hyötyläinen; S-K Herukka; M Sysi-Aho; I Mattila; T Seppänan-Laakso; V Julkunen; P V Gopalacharyulu; M Hallikainen; J Koikkalainen; M Kivipelto; S Helisalmi; J Lötjönen; H Soininen
Journal:  Transl Psychiatry       Date:  2011-12-13       Impact factor: 6.222

10.  Comparative analysis of cerebrospinal fluid metabolites in Alzheimer's disease and idiopathic normal pressure hydrocephalus in a Japanese cohort.

Authors:  Yuki Nagata; Akiyoshi Hirayama; Satsuki Ikeda; Aoi Shirahata; Futaba Shoji; Midori Maruyama; Mitsunori Kayano; Masahiko Bundo; Kotaro Hattori; Sumiko Yoshida; Yu-Ichi Goto; Katsuya Urakami; Tomoyoshi Soga; Kouichi Ozaki; Shumpei Niida
Journal:  Biomark Res       Date:  2018-01-22
View more
  2 in total

1.  Integrative Metabolomic Characterization Reveals the Mediating Effect of Bifidobacterium breve on Amino Acid Metabolism in a Mouse Model of Alzheimer's Disease.

Authors:  Guangsu Zhu; Min Guo; Jianxin Zhao; Hao Zhang; Gang Wang; Wei Chen
Journal:  Nutrients       Date:  2022-02-09       Impact factor: 5.717

2.  Human metabolite detection by surface-enhanced Raman spectroscopy.

Authors:  Yao Lu; Li Lin; Jian Ye
Journal:  Mater Today Bio       Date:  2022-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.